F

Fulcrum Therapeutics
D

FULC

6.88000
USD
-0.04
(-0.58%)
مفتوح الان
حجم التداول
3,345
الربح لكل سهم
-1
العائد الربحي
-
P/E
-688
حجم السوق
371,377,625
أصول ذات صلة
E
ENJ
-0.080
(-0.40%)
20.000 USD
L
LINK
0.07000
(1.00%)
7.07000 USD
S
SAND
0.580
(6.00%)
10.240 USD
المزيد
الأخبار المقالات

العنوان: Fulcrum Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.